NS · Pharmaceuticals

Marksans Pharma Ltd (MARKSANS)

Pharmaceuticals & Biotechnology

Marksans Pharma Ltd (MARKSANS) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $120.18B, P/E ratio is 39.94, net margin is 16.9%, dividend yield is 0.30%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MARKSANS

Market cap

$120.18B

P/E ratio

39.94

Net margin

16.9%

Dividend yield

0.30%

Marksans Pharma Ltd (MARKSANS) — FAQ

What is Marksans Pharma Ltd's market cap?

Marksans Pharma Ltd (MARKSANS) has a reported market cap of $120.18B (data as of 2026-07-11).

What is MARKSANS's P/E ratio?

The price-to-earnings (P/E) ratio for Marksans Pharma Ltd (MARKSANS) is 39.94 (data as of 2026-07-11).

Does Marksans Pharma Ltd pay a dividend?

Marksans Pharma Ltd (MARKSANS) shows a reported dividend yield of 0.30%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-11).

What sector is Marksans Pharma Ltd in?

Marksans Pharma Ltd (MARKSANS) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is MARKSANS listed on?

MARKSANS is listed on NS.

What is Marksans Pharma Ltd's net margin?

Marksans Pharma Ltd (MARKSANS) reports a net margin of 16.9% (data as of 2026-07-11).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)